All Industries

Top Biotech Companies

7,732 Biotech companies, sorted by total funding raised.

Celularity

Celularity is a biotechnology company developing off-the-shelf placental-derived allogeneic cell ...

Florham Park, United States51–200Biotech, Healthcare
Extension RoundTotal funding$645.0MJan 2021
insitro

High-quality perturbational data generation and AI to discover new targets and enable drug discov...

South San Francisco, United States201–500Artificial Intelligence, Healthcare
Series CTotal funding$643.0MMar 2021
Insilico MedicineIPO

AI-driven drug discovery company using generative AI and deep learning to design novel drug candi...

Hong Kong, Hong Kong201–500Artificial Intelligence, Biotech
Series ETotal funding$632.8MMar 2026
Chai Discovery

Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...

San Francisco, United States11–50Artificial Intelligence, Biotech
Series CTotal funding$630.0MJul 2026
Color

Population-scale health company delivering genetic testing, cancer screening, and virtual clinica...

Burlingame, United States501–1000Life Sciences, Biotech
Series ETotal funding$614.0MNov 2021
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
Varda

In-space pharmaceutical manufacturing company that designs, builds, and flies spacecraft to proce...

El Segundo, United States51–200Biotech, Manufacturing
Series DTotal funding$610.3MSep 2026
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech, Oncology
Private EquityTotal funding$607.0MJan 2024
Century TherapeuticsIPO

Century Therapeutics develops allogeneic iPSC-derived NK and T cell therapies for cancer and auto...

Philadelphia, United States51–200Biotech, Healthcare
Corporate RoundTotal funding$605.0MJan 2026
TrialSpark

Clinical trial site network and operations

New York, United States51–200Biotech, Healthcare
Series CTotal funding$598.0MJan 2024
Edgewise TherapeuticsIPO

Edgewise Therapeutics develops novel medicines for people living with serious cardiovascular dise...

Boulder, United States51–200Biotech, Healthcare
Growth EquityTotal funding$585.0MApr 2025
ImmunovantIPO

Clinical-stage immunology company developing targeted anti-FcRn therapies for people with autoimm...

New York, United States51–200Biotech, Healthcare
AngelTotal funding$585.0MOct 2019
UPSIDE Foods

UPSIDE Foods grows cultivated chicken from animal cells in nutrient-fed tanks, producing real mea...

Berkeley, United States201–500Biotech, Food Tech
Series CTotal funding$583.0MApr 2022
Colossal Biosciences

De-extinction and genetic engineering company working to bring back the woolly mammoth and other ...

Dallas, United States51–200Biotech
Series DTotal funding$583.0MSep 2025
Corxel

Biopharmaceutical company

United States51–200Biotech, Healthcare
Series DTotal funding$581.5MJan 2026
Phathom PharmaceuticalsIPO

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing ...

Florham Park, United States201–500Biotech, Healthcare
Venture RoundTotal funding$580.3MJan 2026
TubulisAcquired

Development of enhanced antibody-drug conjugates for improved cancer treatment

Munich, Germany51–200Biotech, Healthcare
Series CTotal funding$578.4MOct 2025
Rakuten Medical

Global biotechnology company developing and commercializing precision, cell-targeting therapies b...

San Diego, United StatesBiotech, Life Sciences
Series FTotal funding$575.0MJan 2026
Aviceda

World leader in glyco-immune checkpoint therapeutics developing immune-mediated therapies for pat...

Cambridge, United States51–200Biotech, Healthcare
Series CTotal funding$572.6MJan 2025
Nimbus Therapeutics

Nimbus Therapeutics is a clinical-stage biotech developing novel small molecule medicines using s...

Cambridge, United States51–200Biotech, Healthcare
Growth EquityTotal funding$572.0MSep 2023
Orca Bio

Orca Bio develops precision allogeneic cell therapies that use regulatory T cells to improve outc...

Menlo Park, United States51–200Biotech, Healthcare
Series FTotal funding$567.0MDec 2025
Cardurion

Cardurion Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and ...

Burlington, United States11–50Biotech, Healthcare
Series BTotal funding$560.0MJul 2024
Freenome

Freenome develops blood-based cancer screening tests using computational biology, machine learnin...

South San Francisco, United States501–1000Artificial Intelligence, Biotech
Series ETotal funding$554.0MFeb 2024
KardiganIPO

Cardiovascular drug development company focused on making cardiovascular disease curable and prev...

South San Francisco, United States51–200Biotech, Healthcare
Series BTotal funding$554.0MOct 2025
CelcuityIPO

Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...

Minneapolis, United States51–200Biotech, Diagnostics
ConvertibleTotal funding$550.1MAug 2025